+1 1 0
Published 4 years ago by shirawinget with 0 Comments

BOTOX or NEWTOX: Which One Is Better?

We’ve all heard of BOTOX, but are you familiar with NEWTOX? Jeuveau, for which NEWTOX is a catchy advertising slogan, is the latest aesthetic injectable neurotoxin on the block, and it seems set to give BOTOX a run for their money.

  • We’ve all heard of BOTOX, but are you familiar with NEWTOX? Jeuveau, for which NEWTOX is a catchy advertising slogan, is the latest aesthetic injectable neurotoxin on the block, and it seems set to give BOTOX a run for their money.

    There are many reasons why patients who regularly undergo BOTOX treatments may want to consider switching over to Jeuveau, and many reasons for newcomers to the botulinum toxins world to look at this newcomer.

    Ahead, we’ll take you through the ins and outs of Jeuveau and find out which is the best: BOTOX or NEWTOX?

  • What Are Botulinum Toxins?

    Botulinum toxins, from which BOTOX derives its name, is a type of neurotoxin that can paralyze nerve cells and thus alter the function of nerve tissue. They can either be produced by bacteria, which is the case with BOTOX, or they can be chemical, like ethanol, for example.

    Due to the manner through which our nerve tissue can regenerate itself, the effects of botulinum toxin aren't permanent. Once the BOTOX or Jeuveau has paralyzed off any nerve cells in certain areas, the cells will slowly start to grow back from their own accord, usually after around 3 months. By the same token, any muscle tissue or skin won’t be damaged by the toxin so there’s no need to be concerned about any permanent alterations to your appearance.

    It has become something of an urban myth over the years that botulinum toxins can “freeze” your face, but in reality, it couldn’t be further from the truth. Even if you aren’t happy with the results of your treatment, all you need to do is wait and don’t undergo any further follow-up procedures and your face will eventually return to normal.

  • What Is Jeuveau or Newtox?

    Jeuveau is a brand of injectable botulinum toxin type A neuromodulator. A brand-new addition to the neurotoxins family, and essentially the same as BOTOX, Jeuveau has been FDA approved for the treatment of wrinkles and fine lines on the face, and specifically in the areas around the eyebrows (the glabellar region).

    Since its inception, Jeuveau has presented itself as a newer and more affordable alternative to BOTOX, hence its promotion under the term #NEWTOX. It has also been frequently targeted towards a younger crowd than BOTOX typically has been, aiming to treat any early aging signs that are starting to appear.

  • What Is the Difference Between Botox and Jeuveau?

    Due to Jeuveau being such a newcomer to the world of neurotoxins, despite essentially being the same as BOTOX in most respects, it is yet to have close to BOTOX’s reputation as an established brand. It is expected, however, that it won’t take long for Jeuveau to build up a strong following due to its more attractive price point. Ultimately the decision on whether to go for Jeuveau or BOTOX will come down to the personal choice of the patient and the amount of experience that the administrator has with Jeuveau, however, the procedure that Jeuveau follows is exactly the same as BOTOX and other neurotoxin brands and is accepted by all aesthetic clinicians.

    Jeuveau’s effectiveness and safety profile are fairly similar to that of BOTOX, so the two can be substituted for one another with no issues. Many who were patients of BOTOX treatments in the past switched over to Jeuveau because they’re essentially the same product and can produce the same results. The two having the same efficacy profile is the reason for the two products’ ability to be interchanged, rather than any similar compounds.

  • Jeuveau: A More Affordable Alternative to Botox

    Perhaps the most exciting feature of Jeuveau, when compared to BOTOX, is its price. Or, more precisely, its lower price. With a projected price 25% lower than that of BOTOX, the company behind Jeuveau, Evolus, is certainly trying to lay their claim to the medical aesthetics industry.

    Wrinkle reduction is the most popular procedure in the medical aesthetics industry, and the largest sector of it is neurotoxins, and there’s none more dominant in this area than BOTOX. Allergan has been dominating the market with as much as 70% of the market share, with alternative procedures Dysport and Xeomin holding 20% and 10% respectively. As much as $1.2 billion are generated by the industry in the U.S. alone, and Jeuveau seems to be after a piece of the pie.

    There’s also one other advantage that Jeuveau holds over the alternatives, and that’s that it has only been developed with aesthetic purposes in mind. This means that Evolus can be more flexible with their pricing, and can create a much more efficient promotional strategy.

  • Not Responding to BOTOX? Try Jeuveau

    Over time, some patients may start to develop something of an immunity to BOTOX injections. Allergan, the company behind BOTOX, put it best themselves when they said, “Occasionally some patients may develop an immune response to BOTOX/BOTOX Cosmetic that may reduce the effectiveness of treatment. This is because BOTOX/BOTOX Cosmetic is a protein complex, and in some patients, the body’s immune system may respond by producing “blocking” (or neutralizing) antibodies capable of inactivating the protein’s biological activity. Antibody formation is more of a concern when patients must receive frequent injections or when it is used to treat medical conditions such as cervical dystonia that require higher doses. However, recent long term studies have indicated immunogenicity to be a minor concern even with that treatment. Both the BOTOX/BOTOX Cosmetic labels advise that the potential for antibody formation may be minimized by injecting with the lowest effective dose given at the longest possible intervals between injections.”

    To put it simply, BOTOX resistance can occur in some patients, and for those that are either immune from the get-go (although this will only be around 1% to 3% of patients), or for those who start to develop a resistance after several procedures, a switch to Jeuveau could do the trick and help them to continue to achieve the results that they desire from the treatment.

    Dr. Ran Y. Rubinstein M.D. of Laser & Cosmetic Surgery Specialists, PC is proud to offer the latest advancements in dermal fillers Jeuveau by Evolus. Contact us today to schedule a consultation to learn more about how you can benefit from Jeuveau injections.


Join the Discussion

  • Auto Tier
  • All
  • 1
  • 2
  • 3
Post Comment

Here are some other snaps you may like...